Publication at Faculty of Medicine in Hradec Králové |
2008
Abstract
Several randomized clinical trials in multiple myeloma completed in the last two decades have clearly shown that high-dose chemotherapy with hematopoietic stem cell support has significantly better therapy results than conventional chemotherapy.